Vargeese, Chandra,Meena,Svrzikapa, Nenad,Mohapatra, Susovan,Francis, Christopher J.,Verdine, Gregory L.,Sokolovska, Anna
申请号：
AU2016297155
公开号：
AU2016297155A1
申请日:
2016.07.22
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Among other things, the present disclosure relates to chirally controlled oligonucleotides of select designs, chirally controlled oligonucleotide compositions, and methods of making and using the same. In some embodiments, a provided chirally controlled oligonucleotide composition provides different cleavage patterns of a nucleic acid polymer than a reference oligonucleotide composition. In some embodiments, a provided chirally controlled oligonucleotide composition provides single site cleavage within a complementary sequence of a nucleic acid polymer. In some embodiments, a chirally controlled oligonucleotide composition has any sequence of bases, and/or pattern or base modifications, sugar modifications, backbone modifications and/or stereochemistry, or combination of these elements, described herein.
